![NecroX-7 [1120332-55-9] NecroX-7 [1120332-55-9]](https://www.targetmol.com/group3/M00/02/9D/CgoaEWY7MyKEBBYcAAAAAFzX2vo660.png)
NecroX-7 [1120332-55-9]
T9948
Overview
- SupplierTargetMol Chemicals
- Product NameNecroX-7 [1120332-55-9]
- Delivery Days Customer9
- Category SupplierChemical
- CertificationResearch Use Only
- Chemical NameNecroX-7
- Estimated Purity98.08%
- Molecular FormulaC24H29N3O3S
- Molecular Weight439.57
- Scientific DescriptionNecroX-7 (LC-280126) is a potent free radical scavenger and HMGB1 (high-mobility group box 1) inhibitor. It serves as an antidote to acetaminophen toxicity and exerts a protective effect by preventing HMGB1 release in ischemia/reperfusion injury. Additionally, NecroX-7 inhibits HMGB1-induced release of TNF and IL-6 and the expression of TLR-4 and receptor for advanced glycation end products. This compound may be used for graft-versus-host disease (GVHD) research [1].
- Shelf life instruction3 years
- SMILESN(C1=C2C(C=C(N2)C3=CC=CC=C3)=CC(CN4CCS(=O)(=O)CC4)=C1)C5CCOCC5
- Storage Instruction-20°C
- UNSPSC12352200
References
- NecroX-7 reduces necrotic core formation in atherosclerotic plaques of Apoe knockout mice. Grootaert MOJ et al., 2016 Sep, AtherosclerosisRead more